Diabetes

A real-world study has found that SGLT2 inhibitors and GLP-1 receptor agonists are more effective at reducing kidney complications in adults with Type 2 diabetes and moderate cardiovascular risk compared to DPP-4 inhibitors and sulfonylureas.

Gestational diabetes screening in low-income countries faces challenges due to the accessibility of oral glucose tolerance tests. A study suggests early-pregnancy HbA1c testing, could reduce OGTT reliance

Diabetes significantly raises the risk of non-ST segment myocardial infarction, with affected patients experiencing worse short- and long-term outcomes. Despite this, they often receive less invasive care.

A study shows that adolescents with prediabetes have a higher risk of developing gestational diabetes and adverse birth outcomes, highlighting the need for early intervention.

Study finds a plant-based diet and exercise outperform standard care in managing type 2 diabetes, improving glycaemic control and reducing medication use.

Diabetes has long been recognised as a risk factor for dementia, but new research reveals its connection to accelerated brain ageing

Circadian rhythm disruption has been strongly linked to the development of Type 2 diabetes.

Findings from the FLOW trial, the first dedicated kidney outcomes trial with semaglutide in patients with Type 2 diabetes and chronic kidney disease, were presented at EASD 2024.